StockData
GeoVax Labs, Inc. logo

GeoVax Labs, Inc. (GOVX) stock

GOVXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.23−0.01 (-4.53%)

Close on Oct 19, 2026Market cap $1.04MP/E –Yield –

GeoVax Labs gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for GeoVax Labs

GeoVax Labs has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More GeoVax Labs figures

See a number that looks wrong?